Clinical Trial Update: Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS) [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study evaluating pramipexole in pediatric patients with idiopathic Restless Legs Syndrome who are on stable optimized doses. The study r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-10-06